Most people take GLP-1 via subcutaneous (under the skin) injections, but more oral alternatives, such as drops, lozenges, and tablets, are becoming available, expanding access for more people
Batch-Tested for Solubility: To protect your research integrity, we pull random samples from every batch at our Hamilton hub
These cases are widely available and specifically designed for injectable medications
Although a number of possible circumstances could cause an ACO's assigned beneficiary population in the benchmark years to fall below 5,000 assigned beneficiaries during its agreement period, the proposal to apply alternative performance payment and loss recoupment limits for ACOs with less than 5,000 assigned beneficiaries in any BY is one of several safeguards we believe is necessary to address risk to the program that result from the proposed changes to the eligibility requirements to allow for participation by ACOs that have fewer than 5,000 assigned beneficiaries in BY1, BY2, or both, which we are finalizing with this final rule (see section III.F.4.b.(2)(a) of this final rule)
Asea, Kaur P., eds
Closing Thoughts Keep in mind that this article was written for informational purposes only, and is not intended to substitute or replace medical advice from your provider
